US genomics company patents tailor-made babies but denies plans to ever use it
23andMe have denied that they ever intend to pursue the patent, which offers parents the chance to select traits desired in their babies
Thursday 03 October 2013
Should we be able to tailor-make our children? It is a question that has been fiercely debated in recent times, picking up interest as quickly as the technology surrounding it has progressed.
Now, a patent acquired by 23andMe, a US genomics and biotechnology company, has been made public that seemingly outlines the technology for parents to custom design their babies. 23andMe have denied any such plans, however.
23andMe, who are based in California, are best known for their personal DNA test kits. For $99 (£61), a kit can be ordered, supplying the buyer with instructions on how to collect their own DNA in the form of a saliva sample.
After sending it back to the lab, buyers can expect to receive information on future health risks, DNA relatives and their ancestral history within months. The results can range from a susceptibility to diabetes to a family relative that you never knew existed.
But now, with 23andMe’s patent being made public this week, there has been speculation as to whether the company plan to take things one step further. The patent appears to offer prospective parents the opportunity to pick and choose their future child’s genetic make-up.
There’s also a section on preference towards eye colour, another on likelihood of the child becoming a long distance runner and, somewhat bizarrely, the choice of whether the child has a low – or high – probability of contracting a range of diseases.
However, 23andMe have reacted to the speculation by making a post on their blog denying any claims that they plan to follow-up on the plans outlined in the patent. “The company never pursued the concepts discussed in the patent beyond our Family Traits Inheritance Calculator, nor do we have any plans to do so,” the author of the blog post said.
“Applying for patents is a normal part of our business and we remain committed to our core principals of giving people access to their own genetic data, innovating the model for research and being transparent with our customers about what we are doing.”
An image from 23andMe's patent application showing the gene selection calculator.
Life & Style blogs
Hair loss explained: How and why men go bald
iPhone 6s camera: features to include 4K video camera and flash for selfies
No, a porn star wasn't tricked into performing a sex act on her brother
A pint of water every day is the key to losing weight, scientists say
Ashley Madison hack: Just three in every 10,000 female accounts on infidelity website are real
Labour leadership: Jeremy Corbyn accused of 'deluding' young supporters with 'claptrap'
'Women only' train carriages: Jeremy Corbyn unveils radical move to tackle public harassment
Black holes are a passage to another universe, says Stephen Hawking
Iain Duncan Smith 'should resign over disability benefit death figures', says Jeremy Corbyn
Iain Duncan Smith calls for urgent ESA overhaul as part of drive to cut down welfare costs
Stock up on canned food for stock market crash, warns former Gordon Brown adviser
- 1 Game of Thrones season 6: Jon Snow theorists believe Ned Stark's son may have a twin sister
- 2 Artist takes LSD, draws herself over different stages of the 9-hour trip to show its effects
- 3 Miley Cyrus address Robin Thicke VMA controversy: ‘He wanted me as naked as possible, but I got the heat because I’m a woman’
- 4 A pint of water every day is the key to losing weight, scientists say
- 5 How the NHS is being dismantled in 10 easy steps
iJobs Gadgets & Tech
£40000 - £55000 per annum: Recruitment Genius: This is an exciting opportunity...
£20000 - £40000 per annum: Recruitment Genius: This IT provider for the educat...
£20000 - £25000 per annum: Recruitment Genius: This leader in the e-cigarette ...
£32000 - £40000 per annum: Recruitment Genius: With extensive experience and a...